InvestorsHub Logo
Followers 87
Posts 6765
Boards Moderated 1
Alias Born 09/18/2009

Re: OneDay4488 post# 41208

Tuesday, 12/19/2023 11:55:53 AM

Tuesday, December 19, 2023 11:55:53 AM

Post# of 43137
Well, the problem with management providing updates, even with FLS notice, is that dumbasses get sucked into joining a Class Action Lawsuit, alleging that the company was misleading them. It doesn't matter that the tort lawyers used the ACTIV-5 government-sponsored trial of late stage patients, to dispute the results of the company-sponsored, peer-reviewed LIVE-AIR trial of early stage patients.

Why isn't the tort lawyer suing Lancet and Thorax, who validated our findings?

Because they know better. The peer-reviewers do not have the discretionary power the NIH and FDA has. They have to scientifically corroborate our reported results, which they did. There is nothing arbitrary about their findings. Like teachers used to tell us on math tests, they have to "show their work."
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.